nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—type 2 diabetes mellitus—coronary artery disease	0.423	1	CtDrD
Orlistat—PLA2G7—coronary artery disease	0.3	1	CbGaD
Orlistat—CYP3A4—Ticagrelor—coronary artery disease	0.0102	0.146	CbGbCtD
Orlistat—CYP3A4—Fenofibrate—coronary artery disease	0.0091	0.131	CbGbCtD
Orlistat—CYP3A4—Gemfibrozil—coronary artery disease	0.00728	0.104	CbGbCtD
Orlistat—CYP3A4—Clopidogrel—coronary artery disease	0.00631	0.0905	CbGbCtD
Orlistat—CYP3A4—Eplerenone—coronary artery disease	0.00587	0.0841	CbGbCtD
Orlistat—CYP3A4—Enalapril—coronary artery disease	0.00523	0.075	CbGbCtD
Orlistat—CYP3A4—Rosuvastatin—coronary artery disease	0.00407	0.0583	CbGbCtD
Orlistat—CYP3A4—Ezetimibe—coronary artery disease	0.00407	0.0583	CbGbCtD
Orlistat—CYP3A4—Simvastatin—coronary artery disease	0.00378	0.0542	CbGbCtD
Orlistat—CYP3A4—Lovastatin—coronary artery disease	0.0037	0.053	CbGbCtD
Orlistat—CYP3A4—Pravastatin—coronary artery disease	0.0037	0.053	CbGbCtD
Orlistat—CYP3A4—Atorvastatin—coronary artery disease	0.00337	0.0483	CbGbCtD
Orlistat—CYP3A4—Losartan—coronary artery disease	0.00308	0.0442	CbGbCtD
Orlistat—Ethanolamine Oleate—FABP5—coronary artery disease	0.0026	1	CrCbGaD
Orlistat—ABHD16A—myocardium—coronary artery disease	0.0017	0.0933	CbGeAlD
Orlistat—ABHD12—myocardium—coronary artery disease	0.00159	0.0874	CbGeAlD
Orlistat—DAGLB—heart—coronary artery disease	0.00156	0.0859	CbGeAlD
Orlistat—DAGLA—blood—coronary artery disease	0.0015	0.0827	CbGeAlD
Orlistat—PLA2G7—cardiovascular system—coronary artery disease	0.00119	0.0655	CbGeAlD
Orlistat—ABHD12—heart—coronary artery disease	0.00111	0.061	CbGeAlD
Orlistat—PNLIP—heart—coronary artery disease	0.00111	0.061	CbGeAlD
Orlistat—PNLIP—cardiovascular system—coronary artery disease	0.00105	0.0576	CbGeAlD
Orlistat—ABHD12—cardiac atrium—coronary artery disease	0.000949	0.0522	CbGeAlD
Orlistat—PLA2G7—blood—coronary artery disease	0.000942	0.0518	CbGeAlD
Orlistat—FASN—heart—coronary artery disease	0.000931	0.0512	CbGeAlD
Orlistat—ABHD16A—blood—coronary artery disease	0.000884	0.0486	CbGeAlD
Orlistat—ABHD12—blood—coronary artery disease	0.000828	0.0455	CbGeAlD
Orlistat—PNLIP—blood—coronary artery disease	0.000828	0.0455	CbGeAlD
Orlistat—FASN—blood—coronary artery disease	0.000695	0.0382	CbGeAlD
Orlistat—PLA2G4A—Enalapril—Captopril—coronary artery disease	0.000594	0.383	CbGdCrCtD
Orlistat—PLA2G4A—heart—coronary artery disease	0.000448	0.0246	CbGeAlD
Orlistat—PLA2G4A—cardiovascular system—coronary artery disease	0.000422	0.0232	CbGeAlD
Orlistat—PLA2G4A—blood—coronary artery disease	0.000334	0.0184	CbGeAlD
Orlistat—PLA2G4A—Enalapril—Perindopril—coronary artery disease	0.000321	0.207	CbGdCrCtD
Orlistat—PLA2G4A—Enalapril—Trandolapril—coronary artery disease	0.000251	0.161	CbGdCrCtD
Orlistat—PLA2G4A—Enalapril—Lisinopril—coronary artery disease	0.000196	0.126	CbGdCrCtD
Orlistat—PLA2G4A—Enalapril—Ramipril—coronary artery disease	0.00019	0.122	CbGdCrCtD
Orlistat—CYP3A4—blood—coronary artery disease	0.00011	0.00606	CbGeAlD
Orlistat—Asthenia—Olmesartan—coronary artery disease	3.32e-05	0.000339	CcSEcCtD
Orlistat—Headache—Clopidogrel—coronary artery disease	3.32e-05	0.000339	CcSEcCtD
Orlistat—Rash—Lovastatin—coronary artery disease	3.32e-05	0.000338	CcSEcCtD
Orlistat—Dermatitis—Lovastatin—coronary artery disease	3.32e-05	0.000338	CcSEcCtD
Orlistat—Dyspepsia—Losartan—coronary artery disease	3.31e-05	0.000338	CcSEcCtD
Orlistat—Feeling abnormal—Perindopril—coronary artery disease	3.31e-05	0.000337	CcSEcCtD
Orlistat—Headache—Lovastatin—coronary artery disease	3.3e-05	0.000336	CcSEcCtD
Orlistat—Pruritus—Valsartan—coronary artery disease	3.29e-05	0.000336	CcSEcCtD
Orlistat—Dry mouth—Ramipril—coronary artery disease	3.29e-05	0.000336	CcSEcCtD
Orlistat—Myalgia—Timolol—coronary artery disease	3.29e-05	0.000335	CcSEcCtD
Orlistat—Chest pain—Timolol—coronary artery disease	3.29e-05	0.000335	CcSEcCtD
Orlistat—Vomiting—Ezetimibe—coronary artery disease	3.29e-05	0.000335	CcSEcCtD
Orlistat—Hypersensitivity—Pravastatin—coronary artery disease	3.28e-05	0.000334	CcSEcCtD
Orlistat—Gastrointestinal pain—Perindopril—coronary artery disease	3.28e-05	0.000334	CcSEcCtD
Orlistat—Anxiety—Timolol—coronary artery disease	3.28e-05	0.000334	CcSEcCtD
Orlistat—Angioedema—Lisinopril—coronary artery disease	3.28e-05	0.000334	CcSEcCtD
Orlistat—Pruritus—Olmesartan—coronary artery disease	3.28e-05	0.000334	CcSEcCtD
Orlistat—Decreased appetite—Losartan—coronary artery disease	3.27e-05	0.000333	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	3.27e-05	0.000333	CcSEcCtD
Orlistat—Abdominal pain—Captopril—coronary artery disease	3.27e-05	0.000333	CcSEcCtD
Orlistat—Body temperature increased—Captopril—coronary artery disease	3.27e-05	0.000333	CcSEcCtD
Orlistat—Dizziness—Simvastatin—coronary artery disease	3.26e-05	0.000332	CcSEcCtD
Orlistat—Rash—Ezetimibe—coronary artery disease	3.26e-05	0.000332	CcSEcCtD
Orlistat—Dermatitis—Ezetimibe—coronary artery disease	3.26e-05	0.000332	CcSEcCtD
Orlistat—Discomfort—Timolol—coronary artery disease	3.25e-05	0.000331	CcSEcCtD
Orlistat—Asthenia—Niacin—coronary artery disease	3.25e-05	0.000331	CcSEcCtD
Orlistat—Fatigue—Losartan—coronary artery disease	3.25e-05	0.000331	CcSEcCtD
Orlistat—Headache—Ezetimibe—coronary artery disease	3.24e-05	0.00033	CcSEcCtD
Orlistat—Malaise—Lisinopril—coronary artery disease	3.23e-05	0.00033	CcSEcCtD
Orlistat—Anaphylactic shock—Ramipril—coronary artery disease	3.23e-05	0.000329	CcSEcCtD
Orlistat—Oedema—Ramipril—coronary artery disease	3.23e-05	0.000329	CcSEcCtD
Orlistat—Vertigo—Lisinopril—coronary artery disease	3.22e-05	0.000328	CcSEcCtD
Orlistat—Dry mouth—Timolol—coronary artery disease	3.22e-05	0.000328	CcSEcCtD
Orlistat—Pain—Losartan—coronary artery disease	3.22e-05	0.000328	CcSEcCtD
Orlistat—Vomiting—Eplerenone—coronary artery disease	3.22e-05	0.000328	CcSEcCtD
Orlistat—Feeling abnormal—Furosemide—coronary artery disease	3.21e-05	0.000328	CcSEcCtD
Orlistat—Nausea—Fenofibrate—coronary artery disease	3.21e-05	0.000327	CcSEcCtD
Orlistat—Pruritus—Niacin—coronary artery disease	3.2e-05	0.000326	CcSEcCtD
Orlistat—Asthenia—Pravastatin—coronary artery disease	3.2e-05	0.000326	CcSEcCtD
Orlistat—Gastrointestinal pain—Furosemide—coronary artery disease	3.19e-05	0.000325	CcSEcCtD
Orlistat—Rash—Eplerenone—coronary artery disease	3.19e-05	0.000325	CcSEcCtD
Orlistat—Urticaria—Perindopril—coronary artery disease	3.19e-05	0.000325	CcSEcCtD
Orlistat—Hypersensitivity—Trandolapril—coronary artery disease	3.19e-05	0.000325	CcSEcCtD
Orlistat—Dermatitis—Eplerenone—coronary artery disease	3.19e-05	0.000325	CcSEcCtD
Orlistat—Diarrhoea—Valsartan—coronary artery disease	3.18e-05	0.000324	CcSEcCtD
Orlistat—Hypersensitivity—Enalapril—coronary artery disease	3.17e-05	0.000324	CcSEcCtD
Orlistat—Body temperature increased—Perindopril—coronary artery disease	3.17e-05	0.000323	CcSEcCtD
Orlistat—Abdominal pain—Perindopril—coronary artery disease	3.17e-05	0.000323	CcSEcCtD
Orlistat—Palpitations—Lisinopril—coronary artery disease	3.17e-05	0.000323	CcSEcCtD
Orlistat—Diarrhoea—Olmesartan—coronary artery disease	3.17e-05	0.000323	CcSEcCtD
Orlistat—Headache—Eplerenone—coronary artery disease	3.17e-05	0.000323	CcSEcCtD
Orlistat—Nervous system disorder—Ramipril—coronary artery disease	3.17e-05	0.000323	CcSEcCtD
Orlistat—Oedema—Timolol—coronary artery disease	3.16e-05	0.000321	CcSEcCtD
Orlistat—Anaphylactic shock—Timolol—coronary artery disease	3.16e-05	0.000321	CcSEcCtD
Orlistat—Pruritus—Pravastatin—coronary artery disease	3.15e-05	0.000321	CcSEcCtD
Orlistat—Nausea—Clopidogrel—coronary artery disease	3.15e-05	0.000321	CcSEcCtD
Orlistat—Skin disorder—Ramipril—coronary artery disease	3.13e-05	0.000319	CcSEcCtD
Orlistat—Infection—Timolol—coronary artery disease	3.13e-05	0.000319	CcSEcCtD
Orlistat—Vomiting—Simvastatin—coronary artery disease	3.13e-05	0.000319	CcSEcCtD
Orlistat—Hypersensitivity—Telmisartan—coronary artery disease	3.13e-05	0.000319	CcSEcCtD
Orlistat—Cough—Lisinopril—coronary artery disease	3.13e-05	0.000319	CcSEcCtD
Orlistat—Nausea—Lovastatin—coronary artery disease	3.13e-05	0.000319	CcSEcCtD
Orlistat—Hyperhidrosis—Ramipril—coronary artery disease	3.12e-05	0.000318	CcSEcCtD
Orlistat—Rash—Simvastatin—coronary artery disease	3.11e-05	0.000317	CcSEcCtD
Orlistat—Dermatitis—Simvastatin—coronary artery disease	3.1e-05	0.000316	CcSEcCtD
Orlistat—Asthenia—Trandolapril—coronary artery disease	3.1e-05	0.000316	CcSEcCtD
Orlistat—Feeling abnormal—Losartan—coronary artery disease	3.1e-05	0.000316	CcSEcCtD
Orlistat—Urticaria—Furosemide—coronary artery disease	3.1e-05	0.000316	CcSEcCtD
Orlistat—Diarrhoea—Niacin—coronary artery disease	3.1e-05	0.000315	CcSEcCtD
Orlistat—Nervous system disorder—Timolol—coronary artery disease	3.09e-05	0.000315	CcSEcCtD
Orlistat—Asthenia—Enalapril—coronary artery disease	3.09e-05	0.000315	CcSEcCtD
Orlistat—Headache—Simvastatin—coronary artery disease	3.09e-05	0.000315	CcSEcCtD
Orlistat—Abdominal pain—Furosemide—coronary artery disease	3.08e-05	0.000314	CcSEcCtD
Orlistat—Body temperature increased—Furosemide—coronary artery disease	3.08e-05	0.000314	CcSEcCtD
Orlistat—Gastrointestinal pain—Losartan—coronary artery disease	3.08e-05	0.000314	CcSEcCtD
Orlistat—Dizziness—Valsartan—coronary artery disease	3.08e-05	0.000314	CcSEcCtD
Orlistat—Nausea—Ezetimibe—coronary artery disease	3.07e-05	0.000313	CcSEcCtD
Orlistat—Skin disorder—Timolol—coronary artery disease	3.06e-05	0.000312	CcSEcCtD
Orlistat—Dizziness—Olmesartan—coronary artery disease	3.06e-05	0.000312	CcSEcCtD
Orlistat—Pruritus—Trandolapril—coronary artery disease	3.06e-05	0.000312	CcSEcCtD
Orlistat—Chest pain—Lisinopril—coronary artery disease	3.05e-05	0.000311	CcSEcCtD
Orlistat—Myalgia—Lisinopril—coronary artery disease	3.05e-05	0.000311	CcSEcCtD
Orlistat—Hyperhidrosis—Timolol—coronary artery disease	3.05e-05	0.000311	CcSEcCtD
Orlistat—Asthenia—Telmisartan—coronary artery disease	3.05e-05	0.000311	CcSEcCtD
Orlistat—Pruritus—Enalapril—coronary artery disease	3.05e-05	0.000311	CcSEcCtD
Orlistat—Diarrhoea—Pravastatin—coronary artery disease	3.05e-05	0.000311	CcSEcCtD
Orlistat—Anxiety—Lisinopril—coronary artery disease	3.04e-05	0.00031	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	3.03e-05	0.000309	CcSEcCtD
Orlistat—Discomfort—Lisinopril—coronary artery disease	3.02e-05	0.000307	CcSEcCtD
Orlistat—Pruritus—Telmisartan—coronary artery disease	3.01e-05	0.000306	CcSEcCtD
Orlistat—Nausea—Eplerenone—coronary artery disease	3e-05	0.000306	CcSEcCtD
Orlistat—Dizziness—Niacin—coronary artery disease	2.99e-05	0.000305	CcSEcCtD
Orlistat—Urticaria—Losartan—coronary artery disease	2.99e-05	0.000305	CcSEcCtD
Orlistat—Dry mouth—Lisinopril—coronary artery disease	2.99e-05	0.000304	CcSEcCtD
Orlistat—Body temperature increased—Losartan—coronary artery disease	2.98e-05	0.000303	CcSEcCtD
Orlistat—Abdominal pain—Losartan—coronary artery disease	2.98e-05	0.000303	CcSEcCtD
Orlistat—Asthenia—Captopril—coronary artery disease	2.97e-05	0.000302	CcSEcCtD
Orlistat—Diarrhoea—Trandolapril—coronary artery disease	2.96e-05	0.000302	CcSEcCtD
Orlistat—Vomiting—Valsartan—coronary artery disease	2.96e-05	0.000302	CcSEcCtD
Orlistat—Diarrhoea—Enalapril—coronary artery disease	2.95e-05	0.0003	CcSEcCtD
Orlistat—Dizziness—Pravastatin—coronary artery disease	2.95e-05	0.0003	CcSEcCtD
Orlistat—Vomiting—Olmesartan—coronary artery disease	2.94e-05	0.0003	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.94e-05	0.0003	CcSEcCtD
Orlistat—Rash—Valsartan—coronary artery disease	2.93e-05	0.000299	CcSEcCtD
Orlistat—Dermatitis—Valsartan—coronary artery disease	2.93e-05	0.000299	CcSEcCtD
Orlistat—Nausea—Simvastatin—coronary artery disease	2.93e-05	0.000298	CcSEcCtD
Orlistat—Anaphylactic shock—Lisinopril—coronary artery disease	2.93e-05	0.000298	CcSEcCtD
Orlistat—Oedema—Lisinopril—coronary artery disease	2.93e-05	0.000298	CcSEcCtD
Orlistat—Pruritus—Captopril—coronary artery disease	2.92e-05	0.000298	CcSEcCtD
Orlistat—Rash—Olmesartan—coronary artery disease	2.92e-05	0.000298	CcSEcCtD
Orlistat—Insomnia—Ramipril—coronary artery disease	2.92e-05	0.000297	CcSEcCtD
Orlistat—Dermatitis—Olmesartan—coronary artery disease	2.92e-05	0.000297	CcSEcCtD
Orlistat—Headache—Valsartan—coronary artery disease	2.92e-05	0.000297	CcSEcCtD
Orlistat—Diarrhoea—Telmisartan—coronary artery disease	2.91e-05	0.000296	CcSEcCtD
Orlistat—Infection—Lisinopril—coronary artery disease	2.91e-05	0.000296	CcSEcCtD
Orlistat—Headache—Olmesartan—coronary artery disease	2.9e-05	0.000296	CcSEcCtD
Orlistat—Paraesthesia—Ramipril—coronary artery disease	2.9e-05	0.000295	CcSEcCtD
Orlistat—Asthenia—Perindopril—coronary artery disease	2.88e-05	0.000293	CcSEcCtD
Orlistat—Vomiting—Niacin—coronary artery disease	2.88e-05	0.000293	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Timolol—coronary artery disease	2.87e-05	0.000293	CcSEcCtD
Orlistat—Hypersensitivity—Furosemide—coronary artery disease	2.87e-05	0.000293	CcSEcCtD
Orlistat—Dizziness—Trandolapril—coronary artery disease	2.86e-05	0.000292	CcSEcCtD
Orlistat—Insomnia—Timolol—coronary artery disease	2.85e-05	0.000291	CcSEcCtD
Orlistat—Rash—Niacin—coronary artery disease	2.85e-05	0.000291	CcSEcCtD
Orlistat—Dermatitis—Niacin—coronary artery disease	2.85e-05	0.00029	CcSEcCtD
Orlistat—Dizziness—Enalapril—coronary artery disease	2.85e-05	0.00029	CcSEcCtD
Orlistat—Skin disorder—Lisinopril—coronary artery disease	2.84e-05	0.00029	CcSEcCtD
Orlistat—Dyspepsia—Ramipril—coronary artery disease	2.84e-05	0.000289	CcSEcCtD
Orlistat—Pruritus—Perindopril—coronary artery disease	2.84e-05	0.000289	CcSEcCtD
Orlistat—Headache—Niacin—coronary artery disease	2.83e-05	0.000289	CcSEcCtD
Orlistat—Paraesthesia—Timolol—coronary artery disease	2.83e-05	0.000289	CcSEcCtD
Orlistat—Vomiting—Pravastatin—coronary artery disease	2.83e-05	0.000289	CcSEcCtD
Orlistat—Hyperhidrosis—Lisinopril—coronary artery disease	2.83e-05	0.000288	CcSEcCtD
Orlistat—Diarrhoea—Captopril—coronary artery disease	2.83e-05	0.000288	CcSEcCtD
Orlistat—Dizziness—Telmisartan—coronary artery disease	2.81e-05	0.000286	CcSEcCtD
Orlistat—Rash—Pravastatin—coronary artery disease	2.81e-05	0.000286	CcSEcCtD
Orlistat—Dermatitis—Pravastatin—coronary artery disease	2.81e-05	0.000286	CcSEcCtD
Orlistat—Decreased appetite—Ramipril—coronary artery disease	2.81e-05	0.000286	CcSEcCtD
Orlistat—Asthenia—Furosemide—coronary artery disease	2.8e-05	0.000285	CcSEcCtD
Orlistat—Headache—Pravastatin—coronary artery disease	2.79e-05	0.000284	CcSEcCtD
Orlistat—Gastrointestinal disorder—Ramipril—coronary artery disease	2.79e-05	0.000284	CcSEcCtD
Orlistat—Fatigue—Ramipril—coronary artery disease	2.78e-05	0.000284	CcSEcCtD
Orlistat—Dyspepsia—Timolol—coronary artery disease	2.78e-05	0.000283	CcSEcCtD
Orlistat—Hypersensitivity—Losartan—coronary artery disease	2.77e-05	0.000283	CcSEcCtD
Orlistat—Nausea—Valsartan—coronary artery disease	2.76e-05	0.000282	CcSEcCtD
Orlistat—Pruritus—Furosemide—coronary artery disease	2.76e-05	0.000281	CcSEcCtD
Orlistat—Nausea—Olmesartan—coronary artery disease	2.75e-05	0.00028	CcSEcCtD
Orlistat—Vomiting—Trandolapril—coronary artery disease	2.75e-05	0.00028	CcSEcCtD
Orlistat—Diarrhoea—Perindopril—coronary artery disease	2.75e-05	0.00028	CcSEcCtD
Orlistat—Decreased appetite—Timolol—coronary artery disease	2.74e-05	0.000279	CcSEcCtD
Orlistat—Vomiting—Enalapril—coronary artery disease	2.74e-05	0.000279	CcSEcCtD
Orlistat—Dizziness—Captopril—coronary artery disease	2.73e-05	0.000278	CcSEcCtD
Orlistat—Rash—Trandolapril—coronary artery disease	2.73e-05	0.000278	CcSEcCtD
Orlistat—Dermatitis—Trandolapril—coronary artery disease	2.73e-05	0.000278	CcSEcCtD
Orlistat—Gastrointestinal disorder—Timolol—coronary artery disease	2.72e-05	0.000278	CcSEcCtD
Orlistat—Fatigue—Timolol—coronary artery disease	2.72e-05	0.000277	CcSEcCtD
Orlistat—Rash—Enalapril—coronary artery disease	2.72e-05	0.000277	CcSEcCtD
Orlistat—Dermatitis—Enalapril—coronary artery disease	2.71e-05	0.000277	CcSEcCtD
Orlistat—Headache—Trandolapril—coronary artery disease	2.71e-05	0.000276	CcSEcCtD
Orlistat—Vomiting—Telmisartan—coronary artery disease	2.7e-05	0.000275	CcSEcCtD
Orlistat—Asthenia—Losartan—coronary artery disease	2.7e-05	0.000275	CcSEcCtD
Orlistat—Headache—Enalapril—coronary artery disease	2.7e-05	0.000275	CcSEcCtD
Orlistat—Pain—Timolol—coronary artery disease	2.7e-05	0.000275	CcSEcCtD
Orlistat—Nausea—Niacin—coronary artery disease	2.69e-05	0.000274	CcSEcCtD
Orlistat—Rash—Telmisartan—coronary artery disease	2.68e-05	0.000273	CcSEcCtD
Orlistat—Dermatitis—Telmisartan—coronary artery disease	2.68e-05	0.000273	CcSEcCtD
Orlistat—Diarrhoea—Furosemide—coronary artery disease	2.67e-05	0.000272	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.67e-05	0.000272	CcSEcCtD
Orlistat—Pruritus—Losartan—coronary artery disease	2.66e-05	0.000271	CcSEcCtD
Orlistat—Headache—Telmisartan—coronary artery disease	2.66e-05	0.000271	CcSEcCtD
Orlistat—Feeling abnormal—Ramipril—coronary artery disease	2.66e-05	0.000271	CcSEcCtD
Orlistat—Dizziness—Perindopril—coronary artery disease	2.65e-05	0.00027	CcSEcCtD
Orlistat—Insomnia—Lisinopril—coronary artery disease	2.65e-05	0.00027	CcSEcCtD
Orlistat—Nausea—Pravastatin—coronary artery disease	2.65e-05	0.00027	CcSEcCtD
Orlistat—Gastrointestinal pain—Ramipril—coronary artery disease	2.64e-05	0.000269	CcSEcCtD
Orlistat—Paraesthesia—Lisinopril—coronary artery disease	2.63e-05	0.000268	CcSEcCtD
Orlistat—Vomiting—Captopril—coronary artery disease	2.63e-05	0.000268	CcSEcCtD
Orlistat—Rash—Captopril—coronary artery disease	2.61e-05	0.000266	CcSEcCtD
Orlistat—Dermatitis—Captopril—coronary artery disease	2.6e-05	0.000265	CcSEcCtD
Orlistat—Feeling abnormal—Timolol—coronary artery disease	2.6e-05	0.000265	CcSEcCtD
Orlistat—Headache—Captopril—coronary artery disease	2.59e-05	0.000264	CcSEcCtD
Orlistat—Gastrointestinal pain—Timolol—coronary artery disease	2.58e-05	0.000263	CcSEcCtD
Orlistat—Dizziness—Furosemide—coronary artery disease	2.58e-05	0.000263	CcSEcCtD
Orlistat—Dyspepsia—Lisinopril—coronary artery disease	2.58e-05	0.000263	CcSEcCtD
Orlistat—Diarrhoea—Losartan—coronary artery disease	2.58e-05	0.000262	CcSEcCtD
Orlistat—Nausea—Trandolapril—coronary artery disease	2.57e-05	0.000262	CcSEcCtD
Orlistat—Urticaria—Ramipril—coronary artery disease	2.56e-05	0.000261	CcSEcCtD
Orlistat—Nausea—Enalapril—coronary artery disease	2.56e-05	0.000261	CcSEcCtD
Orlistat—Vomiting—Perindopril—coronary artery disease	2.55e-05	0.00026	CcSEcCtD
Orlistat—Abdominal pain—Ramipril—coronary artery disease	2.55e-05	0.00026	CcSEcCtD
Orlistat—Body temperature increased—Ramipril—coronary artery disease	2.55e-05	0.00026	CcSEcCtD
Orlistat—Decreased appetite—Lisinopril—coronary artery disease	2.54e-05	0.000259	CcSEcCtD
Orlistat—Rash—Perindopril—coronary artery disease	2.53e-05	0.000258	CcSEcCtD
Orlistat—Dermatitis—Perindopril—coronary artery disease	2.53e-05	0.000258	CcSEcCtD
Orlistat—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.53e-05	0.000257	CcSEcCtD
Orlistat—Nausea—Telmisartan—coronary artery disease	2.52e-05	0.000257	CcSEcCtD
Orlistat—Fatigue—Lisinopril—coronary artery disease	2.52e-05	0.000257	CcSEcCtD
Orlistat—Headache—Perindopril—coronary artery disease	2.51e-05	0.000256	CcSEcCtD
Orlistat—Urticaria—Timolol—coronary artery disease	2.51e-05	0.000255	CcSEcCtD
Orlistat—Pain—Lisinopril—coronary artery disease	2.5e-05	0.000255	CcSEcCtD
Orlistat—Body temperature increased—Timolol—coronary artery disease	2.49e-05	0.000254	CcSEcCtD
Orlistat—Abdominal pain—Timolol—coronary artery disease	2.49e-05	0.000254	CcSEcCtD
Orlistat—Dizziness—Losartan—coronary artery disease	2.49e-05	0.000254	CcSEcCtD
Orlistat—Vomiting—Furosemide—coronary artery disease	2.48e-05	0.000253	CcSEcCtD
Orlistat—Rash—Furosemide—coronary artery disease	2.46e-05	0.000251	CcSEcCtD
Orlistat—Dermatitis—Furosemide—coronary artery disease	2.46e-05	0.00025	CcSEcCtD
Orlistat—Nausea—Captopril—coronary artery disease	2.46e-05	0.00025	CcSEcCtD
Orlistat—Headache—Furosemide—coronary artery disease	2.44e-05	0.000249	CcSEcCtD
Orlistat—Feeling abnormal—Lisinopril—coronary artery disease	2.41e-05	0.000246	CcSEcCtD
Orlistat—Gastrointestinal pain—Lisinopril—coronary artery disease	2.39e-05	0.000244	CcSEcCtD
Orlistat—Vomiting—Losartan—coronary artery disease	2.39e-05	0.000244	CcSEcCtD
Orlistat—Nausea—Perindopril—coronary artery disease	2.38e-05	0.000243	CcSEcCtD
Orlistat—Hypersensitivity—Ramipril—coronary artery disease	2.38e-05	0.000242	CcSEcCtD
Orlistat—Rash—Losartan—coronary artery disease	2.37e-05	0.000242	CcSEcCtD
Orlistat—Dermatitis—Losartan—coronary artery disease	2.37e-05	0.000242	CcSEcCtD
Orlistat—Headache—Losartan—coronary artery disease	2.36e-05	0.00024	CcSEcCtD
Orlistat—Urticaria—Lisinopril—coronary artery disease	2.33e-05	0.000237	CcSEcCtD
Orlistat—Hypersensitivity—Timolol—coronary artery disease	2.32e-05	0.000237	CcSEcCtD
Orlistat—Nausea—Furosemide—coronary artery disease	2.32e-05	0.000236	CcSEcCtD
Orlistat—Asthenia—Ramipril—coronary artery disease	2.32e-05	0.000236	CcSEcCtD
Orlistat—Abdominal pain—Lisinopril—coronary artery disease	2.31e-05	0.000236	CcSEcCtD
Orlistat—Body temperature increased—Lisinopril—coronary artery disease	2.31e-05	0.000236	CcSEcCtD
Orlistat—Pruritus—Ramipril—coronary artery disease	2.28e-05	0.000233	CcSEcCtD
Orlistat—Asthenia—Timolol—coronary artery disease	2.26e-05	0.000231	CcSEcCtD
Orlistat—Nausea—Losartan—coronary artery disease	2.24e-05	0.000228	CcSEcCtD
Orlistat—Pruritus—Timolol—coronary artery disease	2.23e-05	0.000227	CcSEcCtD
Orlistat—Diarrhoea—Ramipril—coronary artery disease	2.21e-05	0.000225	CcSEcCtD
Orlistat—Diarrhoea—Timolol—coronary artery disease	2.16e-05	0.00022	CcSEcCtD
Orlistat—Hypersensitivity—Lisinopril—coronary artery disease	2.16e-05	0.00022	CcSEcCtD
Orlistat—Dizziness—Ramipril—coronary artery disease	2.13e-05	0.000217	CcSEcCtD
Orlistat—Asthenia—Lisinopril—coronary artery disease	2.1e-05	0.000214	CcSEcCtD
Orlistat—Dizziness—Timolol—coronary artery disease	2.09e-05	0.000213	CcSEcCtD
Orlistat—Pruritus—Lisinopril—coronary artery disease	2.07e-05	0.000211	CcSEcCtD
Orlistat—Vomiting—Ramipril—coronary artery disease	2.05e-05	0.000209	CcSEcCtD
Orlistat—Rash—Ramipril—coronary artery disease	2.03e-05	0.000207	CcSEcCtD
Orlistat—Dermatitis—Ramipril—coronary artery disease	2.03e-05	0.000207	CcSEcCtD
Orlistat—Headache—Ramipril—coronary artery disease	2.02e-05	0.000206	CcSEcCtD
Orlistat—Vomiting—Timolol—coronary artery disease	2.01e-05	0.000204	CcSEcCtD
Orlistat—Diarrhoea—Lisinopril—coronary artery disease	2e-05	0.000204	CcSEcCtD
Orlistat—Rash—Timolol—coronary artery disease	1.99e-05	0.000203	CcSEcCtD
Orlistat—Dermatitis—Timolol—coronary artery disease	1.99e-05	0.000203	CcSEcCtD
Orlistat—Headache—Timolol—coronary artery disease	1.98e-05	0.000201	CcSEcCtD
Orlistat—Dizziness—Lisinopril—coronary artery disease	1.94e-05	0.000197	CcSEcCtD
Orlistat—Nausea—Ramipril—coronary artery disease	1.92e-05	0.000195	CcSEcCtD
Orlistat—Nausea—Timolol—coronary artery disease	1.87e-05	0.000191	CcSEcCtD
Orlistat—Vomiting—Lisinopril—coronary artery disease	1.86e-05	0.00019	CcSEcCtD
Orlistat—Rash—Lisinopril—coronary artery disease	1.85e-05	0.000188	CcSEcCtD
Orlistat—Dermatitis—Lisinopril—coronary artery disease	1.84e-05	0.000188	CcSEcCtD
Orlistat—Headache—Lisinopril—coronary artery disease	1.83e-05	0.000187	CcSEcCtD
Orlistat—Nausea—Lisinopril—coronary artery disease	1.74e-05	0.000177	CcSEcCtD
Orlistat—PLA2G4A—Signaling Pathways—SDC1—coronary artery disease	2.87e-06	3.29e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—F2R—coronary artery disease	2.87e-06	3.29e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CKMT1B—coronary artery disease	2.86e-06	3.28e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PRKCD—coronary artery disease	2.86e-06	3.28e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.83e-06	3.24e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FGB—coronary artery disease	2.81e-06	3.22e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR2A—coronary artery disease	2.8e-06	3.21e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—C3—coronary artery disease	2.8e-06	3.2e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ABCA1—coronary artery disease	2.8e-06	3.2e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—EDNRB—coronary artery disease	2.78e-06	3.18e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—THBS1—coronary artery disease	2.74e-06	3.14e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—VEGFA—coronary artery disease	2.73e-06	3.13e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PSMA6—coronary artery disease	2.71e-06	3.11e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PSMB5—coronary artery disease	2.71e-06	3.11e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GOT1—coronary artery disease	2.71e-06	3.1e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GGT1—coronary artery disease	2.71e-06	3.1e-05	CbGpPWpGaD
Orlistat—PNLIP—Disease—IL6—coronary artery disease	2.7e-06	3.09e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—AGT—coronary artery disease	2.66e-06	3.04e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—EDNRA—coronary artery disease	2.62e-06	3.01e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CYBA—coronary artery disease	2.61e-06	2.99e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ADRB1—coronary artery disease	2.61e-06	2.99e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—DUSP6—coronary artery disease	2.6e-06	2.98e-05	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PIK3CA—coronary artery disease	2.58e-06	2.95e-05	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—PIK3CA—coronary artery disease	2.58e-06	2.95e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PLAT—coronary artery disease	2.56e-06	2.93e-05	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PIK3CA—coronary artery disease	2.55e-06	2.93e-05	CbGpPWpGaD
Orlistat—FASN—Disease—TGFB1—coronary artery disease	2.53e-06	2.91e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TGFB1—coronary artery disease	2.51e-06	2.88e-05	CbGpPWpGaD
Orlistat—PNLIP—Disease—AKT1—coronary artery disease	2.49e-06	2.85e-05	CbGpPWpGaD
Orlistat—FASN—Disease—MAPK1—coronary artery disease	2.49e-06	2.85e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—BDKRB2—coronary artery disease	2.47e-06	2.83e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCL12—coronary artery disease	2.47e-06	2.83e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MAPK1—coronary artery disease	2.46e-06	2.82e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—F2—coronary artery disease	2.45e-06	2.81e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—VEGFA—coronary artery disease	2.45e-06	2.81e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL6ST—coronary artery disease	2.44e-06	2.8e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GSTP1—coronary artery disease	2.43e-06	2.79e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—JUNB—coronary artery disease	2.42e-06	2.77e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PLCB1—coronary artery disease	2.41e-06	2.76e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PPARGC1A—coronary artery disease	2.41e-06	2.76e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—HMOX1—coronary artery disease	2.4e-06	2.75e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CAT—coronary artery disease	2.37e-06	2.71e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR7—coronary artery disease	2.36e-06	2.71e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PPAP2B—coronary artery disease	2.33e-06	2.68e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	2.33e-06	2.68e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CKM—coronary artery disease	2.33e-06	2.68e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—APOB—coronary artery disease	2.3e-06	2.63e-05	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL6—coronary artery disease	2.28e-06	2.62e-05	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IL6—coronary artery disease	2.28e-06	2.62e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ITGAV—coronary artery disease	2.25e-06	2.58e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TGFB1—coronary artery disease	2.25e-06	2.58e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—KNG1—coronary artery disease	2.24e-06	2.57e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—POMC—coronary artery disease	2.24e-06	2.56e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CREB1—coronary artery disease	2.24e-06	2.56e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GSTM1—coronary artery disease	2.23e-06	2.56e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AGTR1—coronary artery disease	2.23e-06	2.56e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—MAPK1—coronary artery disease	2.2e-06	2.53e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—LPL—coronary artery disease	2.19e-06	2.51e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CCL2—coronary artery disease	2.19e-06	2.51e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL6R—coronary artery disease	2.18e-06	2.5e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCL10—coronary artery disease	2.18e-06	2.5e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PLG—coronary artery disease	2.17e-06	2.49e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SULT4A1—coronary artery disease	2.17e-06	2.49e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PDK4—coronary artery disease	2.17e-06	2.49e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PYGM—coronary artery disease	2.17e-06	2.49e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	2.17e-06	2.49e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CKMT2—coronary artery disease	2.17e-06	2.49e-05	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—POMC—coronary artery disease	2.16e-06	2.48e-05	CbGpPWpGaD
Orlistat—FASN—Disease—PIK3CA—coronary artery disease	2.16e-06	2.47e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GPX1—coronary artery disease	2.14e-06	2.45e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PIK3CA—coronary artery disease	2.13e-06	2.45e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ADRB2—coronary artery disease	2.12e-06	2.43e-05	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—AKT1—coronary artery disease	2.1e-06	2.41e-05	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—AKT1—coronary artery disease	2.1e-06	2.41e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PRKCE—coronary artery disease	2.09e-06	2.39e-05	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—AKT1—coronary artery disease	2.09e-06	2.39e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CD36—coronary artery disease	2.08e-06	2.39e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SOCS1—coronary artery disease	2.08e-06	2.39e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—S100B—coronary artery disease	2.08e-06	2.38e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PPP2CA—coronary artery disease	2.06e-06	2.36e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SOCS3—coronary artery disease	2.06e-06	2.36e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—KITLG—coronary artery disease	2.03e-06	2.33e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TGFBR2—coronary artery disease	2.03e-06	2.33e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MMP3—coronary artery disease	1.99e-06	2.28e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—STAT5A—coronary artery disease	1.99e-06	2.28e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—MTHFR—coronary artery disease	1.97e-06	2.26e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PFKM—coronary artery disease	1.93e-06	2.22e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GYG1—coronary artery disease	1.93e-06	2.22e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GK—coronary artery disease	1.93e-06	2.22e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—HMGCS2—coronary artery disease	1.93e-06	2.22e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—LDHA—coronary artery disease	1.93e-06	2.22e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GATM—coronary artery disease	1.93e-06	2.22e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APOB—coronary artery disease	1.92e-06	2.2e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—PIK3CA—coronary artery disease	1.91e-06	2.19e-05	CbGpPWpGaD
Orlistat—FASN—Disease—IL6—coronary artery disease	1.91e-06	2.19e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—JAK2—coronary artery disease	1.89e-06	2.17e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—EDN1—coronary artery disease	1.89e-06	2.17e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL6—coronary artery disease	1.89e-06	2.17e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—AGT—coronary artery disease	1.88e-06	2.15e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCL5—coronary artery disease	1.88e-06	2.15e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CSF2—coronary artery disease	1.85e-06	2.12e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FGF1—coronary artery disease	1.85e-06	2.12e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GCH1—coronary artery disease	1.84e-06	2.11e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—AK1—coronary artery disease	1.84e-06	2.11e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—APOE—coronary artery disease	1.84e-06	2.11e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—LPL—coronary artery disease	1.83e-06	2.1e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MEF2C—coronary artery disease	1.82e-06	2.08e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RPS6KB1—coronary artery disease	1.82e-06	2.08e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—APOA1—coronary artery disease	1.82e-06	2.08e-05	CbGpPWpGaD
Orlistat—FASN—Metabolism—PIK3CA—coronary artery disease	1.81e-06	2.07e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ITGB3—coronary artery disease	1.77e-06	2.03e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—MDH2—coronary artery disease	1.77e-06	2.03e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PLCD1—coronary artery disease	1.77e-06	2.03e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—UGCG—coronary artery disease	1.77e-06	2.03e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PPAT—coronary artery disease	1.77e-06	2.03e-05	CbGpPWpGaD
Orlistat—FASN—Disease—AKT1—coronary artery disease	1.76e-06	2.02e-05	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—AKT1—coronary artery disease	1.74e-06	2e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.74e-06	2e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CXCL8—coronary artery disease	1.73e-06	1.98e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PPP2CA—coronary artery disease	1.72e-06	1.97e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PGM1—coronary artery disease	1.7e-06	1.95e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PRKCD—coronary artery disease	1.69e-06	1.94e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR2A—coronary artery disease	1.65e-06	1.9e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—C3—coronary artery disease	1.65e-06	1.89e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PYGB—coronary artery disease	1.64e-06	1.89e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CKB—coronary artery disease	1.64e-06	1.89e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PPARG—coronary artery disease	1.6e-06	1.84e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—POMC—coronary artery disease	1.58e-06	1.81e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HIF1A—coronary artery disease	1.57e-06	1.81e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AGT—coronary artery disease	1.57e-06	1.8e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—AKT1—coronary artery disease	1.56e-06	1.79e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GSTM2—coronary artery disease	1.55e-06	1.77e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PFKFB3—coronary artery disease	1.55e-06	1.77e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—DLAT—coronary artery disease	1.55e-06	1.77e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—COX5B—coronary artery disease	1.55e-06	1.77e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PLIN1—coronary artery disease	1.55e-06	1.77e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—LEP—coronary artery disease	1.54e-06	1.76e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APOE—coronary artery disease	1.54e-06	1.76e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—APOA1—coronary artery disease	1.52e-06	1.74e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—KDR—coronary artery disease	1.51e-06	1.73e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MAPK14—coronary artery disease	1.5e-06	1.72e-05	CbGpPWpGaD
Orlistat—FASN—Metabolism—AKT1—coronary artery disease	1.48e-06	1.69e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ESR1—coronary artery disease	1.47e-06	1.68e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SULT1E1—coronary artery disease	1.47e-06	1.68e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FN1—coronary artery disease	1.45e-06	1.66e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—F2—coronary artery disease	1.45e-06	1.66e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL6ST—coronary artery disease	1.44e-06	1.66e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ALB—coronary artery disease	1.44e-06	1.65e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NFKBIA—coronary artery disease	1.43e-06	1.64e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—AKR1B1—coronary artery disease	1.4e-06	1.6e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—HK2—coronary artery disease	1.4e-06	1.6e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—KIT—coronary artery disease	1.39e-06	1.59e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—NOS3—coronary artery disease	1.38e-06	1.58e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1.34e-06	1.54e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GSK3B—coronary artery disease	1.33e-06	1.53e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—POMC—coronary artery disease	1.32e-06	1.51e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CREB1—coronary artery disease	1.32e-06	1.51e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.31e-06	1.51e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—LCAT—coronary artery disease	1.31e-06	1.51e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCL2—coronary artery disease	1.29e-06	1.48e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APOA4—coronary artery disease	1.29e-06	1.48e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL6R—coronary artery disease	1.29e-06	1.48e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IGF1—coronary artery disease	1.27e-06	1.46e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—MAPK1—coronary artery disease	1.26e-06	1.45e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTGS2—coronary artery disease	1.26e-06	1.44e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.25e-06	1.43e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GCLM—coronary artery disease	1.25e-06	1.43e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.21e-06	1.38e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.21e-06	1.38e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SERPINE1—coronary artery disease	1.21e-06	1.38e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.19e-06	1.36e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—HADH—coronary artery disease	1.17e-06	1.34e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.17e-06	1.34e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FGF2—coronary artery disease	1.17e-06	1.34e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NOS3—coronary artery disease	1.15e-06	1.32e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—JAK2—coronary artery disease	1.12e-06	1.28e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GPX2—coronary artery disease	1.11e-06	1.27e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APOA2—coronary artery disease	1.11e-06	1.27e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	1.11e-06	1.27e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—HK1—coronary artery disease	1.1e-06	1.26e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GPX4—coronary artery disease	1.1e-06	1.26e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ABCG5—coronary artery disease	1.1e-06	1.26e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SULT1A1—coronary artery disease	1.1e-06	1.26e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PIK3CA—coronary artery disease	1.1e-06	1.26e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—HADHA—coronary artery disease	1.08e-06	1.24e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.07e-06	1.23e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—LPA—coronary artery disease	1.06e-06	1.21e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.03e-06	1.18e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCL8—coronary artery disease	1.02e-06	1.17e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APOA5—coronary artery disease	1.02e-06	1.16e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—P4HB—coronary artery disease	9.96e-07	1.14e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	9.78e-07	1.12e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CASP3—coronary artery disease	9.78e-07	1.12e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL6—coronary artery disease	9.72e-07	1.11e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCND1—coronary artery disease	9.52e-07	1.09e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MMP9—coronary artery disease	9.24e-07	1.06e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—VCAN—coronary artery disease	9.22e-07	1.06e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ALDOA—coronary artery disease	9.15e-07	1.05e-05	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—AKT1—coronary artery disease	8.96e-07	1.03e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—DCN—coronary artery disease	8.88e-07	1.02e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ALDH2—coronary artery disease	8.64e-07	9.9e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—HBA1—coronary artery disease	8.42e-07	9.65e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—LIPC—coronary artery disease	8.42e-07	9.65e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	8.42e-07	9.65e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CYP2C19—coronary artery disease	8.42e-07	9.65e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APOC3—coronary artery disease	8.37e-07	9.59e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—LDLR—coronary artery disease	8.31e-07	9.53e-06	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—VEGFA—coronary artery disease	8.3e-07	9.51e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GSTT1—coronary artery disease	8.22e-07	9.42e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SLC9A1—coronary artery disease	8.22e-07	9.42e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GCLC—coronary artery disease	8.12e-07	9.31e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CETP—coronary artery disease	8.12e-07	9.31e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—SDC1—coronary artery disease	8.03e-07	9.21e-06	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PIK3CA—coronary artery disease	7.75e-07	8.89e-06	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TGFB1—coronary artery disease	7.62e-07	8.73e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PSMB5—coronary artery disease	7.59e-07	8.7e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PSMA6—coronary artery disease	7.59e-07	8.7e-06	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MAPK1—coronary artery disease	7.47e-07	8.56e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CTGF—coronary artery disease	7.41e-07	8.5e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—HMGCR—coronary artery disease	7.34e-07	8.42e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GOT2—coronary artery disease	7.34e-07	8.42e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PLCB1—coronary artery disease	6.75e-07	7.74e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ABCA1—coronary artery disease	6.55e-07	7.5e-06	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PIK3CA—coronary artery disease	6.48e-07	7.43e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GGT1—coronary artery disease	6.34e-07	7.27e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GOT1—coronary artery disease	6.34e-07	7.27e-06	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—AKT1—coronary artery disease	6.33e-07	7.26e-06	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL6—coronary artery disease	5.74e-07	6.58e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GSTP1—coronary artery disease	5.7e-07	6.53e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	5.64e-07	6.47e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—HMOX1—coronary artery disease	5.62e-07	6.44e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CAT—coronary artery disease	5.54e-07	6.35e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APOB—coronary artery disease	5.38e-07	6.17e-06	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AKT1—coronary artery disease	5.29e-07	6.07e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GSTM1—coronary artery disease	5.23e-07	6e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—LPL—coronary artery disease	5.14e-07	5.89e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GPX1—coronary artery disease	5.01e-07	5.75e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CD36—coronary artery disease	4.88e-07	5.6e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PPP2CA—coronary artery disease	4.82e-07	5.53e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—MTHFR—coronary artery disease	4.63e-07	5.3e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—AGT—coronary artery disease	4.39e-07	5.04e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APOE—coronary artery disease	4.31e-07	4.94e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—APOA1—coronary artery disease	4.26e-07	4.88e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PPARG—coronary artery disease	3.75e-07	4.3e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—POMC—coronary artery disease	3.7e-07	4.24e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ALB—coronary artery disease	3.37e-07	3.87e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NOS3—coronary artery disease	3.23e-07	3.7e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTGS2—coronary artery disease	2.95e-07	3.38e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.82e-07	2.08e-06	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—AKT1—coronary artery disease	1.48e-07	1.7e-06	CbGpPWpGaD
